MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary


Drug Safety Update

August 2022: Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists

  July 2018: Pressurised metered dose inhalers (pMDI): risk of airway  obstruction from aspiration of loose objects

NICE Guidance

  NG115: Chronic obstructive pulmonary disease in over 16s - diagnosis and management, December 2018 (updated July 2019)

Ipratropium and Spiriva Respimat are the only antimuscarinics licensed for asthma and COPD. The rest are licensed for COPD only.

Short-acting bronchodilator

Pack Price
200 dose £5.56
Pack Price
20 unit dose £6.50
60 unit dose

Long acting bronchodilator used twice daily. Each 375 microgram inhalation of aclidinium bromide delivers 322micrograms of aclidinium

Pack Price
60 dose £32.50

Long acting bronchodilator used once daily. Each capsule delivers 55 micrograms of glycopyrronium bromide equivalent to 44 micrograms of glycopyrronium

Pack Price
10 capsule
30 capsule £27.50
6 capsule

Long acting bronchodilator used once daily. Use Spiriva Respimat only when patients are unable to use Spiriva Handihaler.

Pack Price
30 capsule £33.50
60 capsule
Pack Price
30 capsule £34.87
Pack Price
60 dose £23.00

LAMA/LABA combination used once daily

Pack Price
10 capsule £10.83
30 capsule (3 x 10 capsules) £32.50